Community Search
Come Meet Us: Latest News

Lundbeck announces availability of new therapy for rare neurologic disorder

Tuesday, September 2, 2014   (0 Comments)
Share |

 

‎WPC Scientific Update Lead Supporter Lundbeck Announces Availability of NORTHERA™ (droxidopa) Capsules in the U.S. for Symptomatic Neurogenic Orthostatic Hypotension (NOH).


NOH is a Disorder Caused by an Underlying Neurologic Disease (e.g., Parkinson's Disease, Multiple System Atrophy or Pure Autonomic Failure)


Read more: http://bit.ly/1tqDLDR


Membership Management Software Powered by YourMembership  ::  Legal